[路演]盘龙药业：预计下半年逐步扩大盘龙中药配方颗粒销售规模

全景网2025-05-12

5月12日下午，盘龙药业（002864.SZ）2024年度业绩说明会在全景网成功举办。盘龙药业董事长谢晓林、副总裁张德柱、董事会秘书吴杰、财务总监祝凤鸣、独立董事任海云、独立董事牛晓峰、保荐代表人杨圣志等领导嘉宾出席活动并与投资者进行实时在线交流。对于投资者关心的公司中药配方颗粒备案211个品种何时能成为第二增长曲线问题，公司董事会秘书吴杰表示，公司中药配方颗粒今年上半年主要工作是依托已备案品种...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535578734?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-12 20:42","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535578734","market":"sh","top_or_hot":-1,"title":"[路演]盘龙药业：预计下半年逐步扩大盘龙中药配方颗粒销售规模","media":"全景网","content":"<div>\n<p>5月12日下午，盘龙药业（002864.SZ）2024年度业绩说明会在全景网成功举办。盘龙药业董事长谢晓林、副总裁张德柱、董事会秘书吴杰、财务总监祝凤鸣、独立董事任海云、独立董事牛晓峰、保荐代表人杨圣志等领导嘉宾出席活动并与投资者进行实时在线交流。对于投资者关心的公司中药配方颗粒备案211个品种何时能成为第二增长曲线问题，公司董事会秘书吴杰表示，公司中药配方颗粒今年上半年主要工作是依托已备案品种...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505130801459757aa47&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>[路演]盘龙药业：预计下半年逐步扩大盘龙中药配方颗粒销售规模</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n[路演]盘龙药业：预计下半年逐步扩大盘龙中药配方颗粒销售规模\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-12 20:42 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505130801459757aa47&s=b><strong>全景网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>5月12日下午，盘龙药业（002864.SZ）2024年度业绩说明会在全景网成功举办。盘龙药业董事长谢晓林、副总裁张德柱、董事会秘书吴杰、财务总监祝凤鸣、独立董事任海云、独立董事牛晓峰、保荐代表人杨圣志等领导嘉宾出席活动并与投资者进行实时在线交流。对于投资者关心的公司中药配方颗粒备案211个品种何时能成为第二增长曲线问题，公司董事会秘书吴杰表示，公司中药配方颗粒今年上半年主要工作是依托已备案品种...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505130801459757aa47&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"002864","symbol_name":"盘龙药业","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505130801459757aa47&s=b","article_id":"2535578734","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505130801459757aa47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535578734","pubTimestamp":1747053720,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"5月12日下午，盘龙药业2024年度业绩说明会在全景网成功举办。对于投资者关心的公司中药配方颗粒备案211个品种何时能成为第二增长曲线问题，公司董事会秘书吴杰表示，公司中药配方颗粒今年上半年主要工作是依托已备案品种办理各省的挂网准入工作，预计下半年开始发力逐步扩大销售规模，加大优势政策宣讲，扩大盘龙中药配方颗粒在重点市场的品牌力，实现公司第二增长曲线目标。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"561510":"中药ETF华泰柏瑞","562390":"中药ETF银华","002864":"盘龙药业","BK0239":"医药制造"},"translate_title":"[Roadshow] Panlong Pharmaceutical: It is expected to gradually expand the sales scale of Panlong traditional Chinese medicine formula granules in the second half of the year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"561510":0.9,"562390":0.9,"002864":1},"content_text":"5月12日下午，盘龙药业（002864.SZ）2024年度业绩说明会在全景网成功举办。盘龙药业董事长谢晓林、副总裁张德柱、董事会秘书吴杰、财务总监祝凤鸣、独立董事任海云、独立董事牛晓峰、保荐代表人杨圣志等领导嘉宾出席活动并与投资者进行实时在线交流。对于投资者关心的公司中药配方颗粒备案211个品种何时能成为第二增长曲线问题，公司董事会秘书吴杰表示，公司中药配方颗粒今年上半年主要工作是依托已备案品种办理各省的挂网准入工作，预计下半年开始发力逐步扩大销售规模，加大优势政策宣讲，扩大盘龙中药配方颗粒在重点市场的品牌力，实现公司第二增长曲线目标。由于该销售方向正在发展过程中其毛利率处在一个动态变化过程中，当其业绩达到一个相对稳定状态时，其毛利率也相对稳定在一个正常区间。（全景网）了解更多业绩说明会详情，请点击：https://rs.p5w.net/html/147144.shtml","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535578734","isCrawlerRequest":true}